title: Safety of sorafenib therapy in elderly adults with advanced hepatocellular carcinoma.
authors.affiliation: Medical Oncology Unit, Policlinico Umberto I Hospital, University of Rome, Rome, Italy.
authors.forename: Edoardo
authors.initials: E
authors.lastname: Francini
authors.forename: Silvia
authors.initials: S
authors.lastname: Mazzaroppi
authors.forename: Anna I
authors.initials: AI
authors.lastname: Fiaschi
authors.forename: Roberto
authors.initials: R
authors.lastname: Petrioli
authors.forename: Letizia
authors.initials: L
authors.lastname: Laera
authors.forename: Giandomenico
authors.initials: G
authors.lastname: Roviello
authors.forename: Teresa
authors.initials: T
authors.lastname: Pira
authors.forename: Adriano M
authors.initials: AM
authors.lastname: Pellicelli
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Bianco
mesh_terms: D000203:Activities of Daily Living / Q000145:classification; D016907:Adverse Drug Reaction Reporting Systems; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D009367:Neoplasm Staging; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D010671:Phenylurea Compounds / Q000009:adverse effects* / Q000627:therapeutic use*; D000077157:Sorafenib
chemical_list: D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib